Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression

Head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge and identification of novel therapeutic targets is necessary. The receptor tyrosine kinase AXL has been implicated in several tumor entities and a selective AXL small molecule inhibitor (BGB324) is currently being tested in c...

Descripción completa

Detalles Bibliográficos
Autores principales: von Mässenhausen, Anne, Brägelmann, Johannes, Billig, Hannah, Thewes, Britta, Queisser, Angela, Vogel, Wenzel, Kristiansen, Glen, Schröck, Andreas, Bootz, Friedrich, Brossart, Peter, Kirfel, Jutta, Perner, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297642/
https://www.ncbi.nlm.nih.gov/pubmed/28025482
http://dx.doi.org/10.3390/ijms18010007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297642/
https://www.ncbi.nlm.nih.gov/pubmed/28025482
http://dx.doi.org/10.3390/ijms18010007

Ejemplares similares